JP2006520610A - ハイブリッド不変領域を産生するのに用いるベクター - Google Patents

ハイブリッド不変領域を産生するのに用いるベクター Download PDF

Info

Publication number
JP2006520610A
JP2006520610A JP2006509121A JP2006509121A JP2006520610A JP 2006520610 A JP2006520610 A JP 2006520610A JP 2006509121 A JP2006509121 A JP 2006509121A JP 2006509121 A JP2006509121 A JP 2006509121A JP 2006520610 A JP2006520610 A JP 2006520610A
Authority
JP
Japan
Prior art keywords
constant region
region
antibody
chain constant
mouse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006509121A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520610A5 (enExample
Inventor
エス．ボーディッシュ キャサリン
フレデリクソン シャナ
マルヤマ トシアキ
Original Assignee
アレクシオン ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アレクシオン ファーマシューティカルズ， インコーポレイテッド filed Critical アレクシオン ファーマシューティカルズ， インコーポレイテッド
Publication of JP2006520610A publication Critical patent/JP2006520610A/ja
Publication of JP2006520610A5 publication Critical patent/JP2006520610A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2006509121A 2003-03-04 2004-03-04 ハイブリッド不変領域を産生するのに用いるベクター Pending JP2006520610A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45182003P 2003-03-04 2003-03-04
PCT/US2004/006571 WO2004078937A2 (en) 2003-03-04 2004-03-04 Vectors used to create hybrid constant regions

Publications (2)

Publication Number Publication Date
JP2006520610A true JP2006520610A (ja) 2006-09-14
JP2006520610A5 JP2006520610A5 (enExample) 2007-01-11

Family

ID=32962642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509121A Pending JP2006520610A (ja) 2003-03-04 2004-03-04 ハイブリッド不変領域を産生するのに用いるベクター

Country Status (6)

Country Link
US (1) US20070009957A1 (enExample)
EP (1) EP1606387A4 (enExample)
JP (1) JP2006520610A (enExample)
AU (1) AU2004217433A1 (enExample)
CA (1) CA2517519A1 (enExample)
WO (1) WO2004078937A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060057651A1 (en) 2000-12-08 2006-03-16 Bowdish Katherine S Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US7427665B2 (en) 2000-12-08 2008-09-23 Alexion Pharmaceuticals, Inc. Chronic lymphocytic leukemia cell line
US9249229B2 (en) 2000-12-08 2016-02-02 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US7408041B2 (en) 2000-12-08 2008-08-05 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US6803230B2 (en) 2001-04-27 2004-10-12 Alexion Pharmaceuticals, Inc. Phagemid vectors
US8075884B2 (en) 2006-01-12 2011-12-13 Alexion Pharmaceuticals, Inc. Antibodies to OX-2/CD200 and uses thereof
US8986684B2 (en) 2007-07-25 2015-03-24 Alexion Pharmaceuticals, Inc. Methods and compositions for treating autoimmune disease
US20110059471A1 (en) * 2008-03-14 2011-03-10 Medinet Co., Ltd. Antibody having an immune-enhancement function
WO2010039900A2 (en) * 2008-09-30 2010-04-08 Aliva Biopharmaceuticals, Inc. Non-human mammals for the production of chimeric antibodies
HRP20151188T4 (hr) 2010-02-08 2021-10-01 Regeneron Pharmaceuticals, Inc. Miš sa zajedničkim lakim lancem
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
PL3251503T3 (pl) 2010-03-31 2024-07-08 Ablexis, Llc Modyfikacja myszy metodami inżynierii genetycznej w celu wytworzenia przeciwciał chimerycznych
PT3865581T (pt) 2011-08-05 2024-10-04 Regeneron Pharma Murganhos da cadeia leve universal humanizada
CN106255410B (zh) 2014-03-21 2020-01-10 瑞泽恩制药公司 产生单结构域结合蛋白的非人动物
US11111314B2 (en) 2015-03-19 2021-09-07 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
US11761963B2 (en) 2017-09-27 2023-09-19 Alexion Pharmaceuticals, Inc. Biomarker signature for predicting tumor response to anti-CD200 therapy
JP7627413B2 (ja) * 2020-08-21 2025-02-06 ファチアブジェン インコーポレイテッド ガンマ定常領域（Ｃγ１）とイプシロン定常領域（Ｃε２－４）とが融合された重鎖及び軽鎖の定常領域からなる抗体断片及びその用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000510692A (ja) * 1996-05-04 2000-08-22 ゼネカ リミテッド Ｃｅａに対するモノクローナル抗体、その抗体を含む結合体、およびａｄｅｐｔシステムにおけるそれらの治療的使用
WO2002088315A2 (en) * 2001-04-27 2002-11-07 Alexion Pharmaceuticals, Inc. Phagemid vectors
WO2003002608A1 (fr) * 2001-06-28 2003-01-09 Kyowa Hakko Kogyo Co., Ltd. Anticorps humanise contre le facteur-8 de croissance des fibroblastes et fragment de cet anticorps

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US7119248B1 (en) * 1994-04-12 2006-10-10 Miltenyi Biotec Gmbh Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
US6258529B1 (en) * 1994-12-01 2001-07-10 Oravax, Inc. PCR amplification of rearranged genomic variable regions of immunoglobulin genes
IL155977A0 (en) * 2000-11-30 2003-12-23 Medarex Inc Transgenic transchromosomal rodents for making human antibodies
EP2339035A1 (en) * 2000-12-07 2011-06-29 Novartis Vaccines and Diagnostics, Inc. Endogenous retroviruses up-regulated in prostate cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000510692A (ja) * 1996-05-04 2000-08-22 ゼネカ リミテッド Ｃｅａに対するモノクローナル抗体、その抗体を含む結合体、およびａｄｅｐｔシステムにおけるそれらの治療的使用
WO2002088315A2 (en) * 2001-04-27 2002-11-07 Alexion Pharmaceuticals, Inc. Phagemid vectors
WO2003002608A1 (fr) * 2001-06-28 2003-01-09 Kyowa Hakko Kogyo Co., Ltd. Anticorps humanise contre le facteur-8 de croissance des fibroblastes et fragment de cet anticorps

Also Published As

Publication number Publication date
US20070009957A1 (en) 2007-01-11
WO2004078937A2 (en) 2004-09-16
CA2517519A1 (en) 2004-09-16
AU2004217433A1 (en) 2004-09-16
WO2004078937A3 (en) 2005-12-22
EP1606387A2 (en) 2005-12-21
EP1606387A4 (en) 2008-04-23

Similar Documents

Publication Publication Date Title
US20070009957A1 (en) Vectors used to create hybrid constant regions
KR102290949B1 (ko) 신규 항체 라이브러리 제조방법 및 이로부터 제조된 라이브러리
USRE42130E1 (en) Phagemid vectors
AU2015277180A1 (en) A method for directing proteins to specific loci in the genome and uses thereof
CA2471116A1 (en) Method for cloning of variable domain sequences
JPH06121696A (ja) 抗原結合性タンパク質およびその製造方法
CN102770555A (zh) 改善的细菌膜蛋白分泌
EP3440208B1 (en) Vectors for cloning and expression of proteins, methods and applications thereof
AU2003253193B2 (en) Novel tricistronic vectors and uses therefor
WO2020254352A1 (en) Method for the generation of a trivalent antibody expressing cell by targeted integration of multiple expression cassettes in a defined organization
AU2010322202B2 (en) Display of disulfide linked dimeric proteins on filamentous phage
WO2018069416A1 (en) Triple vector for expressing antibody molecules in full therapeutic format
AU2002305246A1 (en) Phagemid vectors
WO2004055182A1 (en) In vivo affinity maturation scheme
WO2003097796A2 (en) T7 bacteriophage display of fabs
WO2003093471A1 (en) Novel 88 phage vectors
CA2448574A1 (en) Novel 33 phage vectors
EP1497421A1 (en) Novel 33 phage vectors
WO2002046436A9 (en) Plasmid vectors

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091119

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100412